Promising New Drug Shows Potential to Slow Alzheimer’s Progression
In a groundbreaking advancement in Alzheimer’s disease research, a team led by Professor Ursula Quitterer at ETH Zurich has developed ...
In a groundbreaking advancement in Alzheimer’s disease research, a team led by Professor Ursula Quitterer at ETH Zurich has developed ...
In a groundbreaking study published in the Journal of Translational Medicine, researchers led by Chi et al. have unveiled promising ...
In a pioneering advance that could redefine therapeutic strategies for neurodegenerative disorders, a team of researchers led by Krasnienkov, D., ...
In a groundbreaking study poised to redefine our understanding of Parkinson’s disease (PD), researchers have unveiled compelling evidence that cerebrospinal ...
Parkinson’s disease (PD) remains one of the most enigmatic neurodegenerative disorders of our time, characterized by its gradual progression and ...
In a groundbreaking study published in Nature Chemical Biology, researchers have made significant strides in understanding the mechanisms of TRMT112 ...
A groundbreaking study published in Nature Communications in 2025 by Martinez-Valbuena, Lee, Santamaria, and colleagues has unveiled compelling evidence for ...
In the quest to unravel the molecular complexities of Parkinson’s disease, the promise of transcriptomic signatures—distinct patterns of gene expression ...
In a groundbreaking study published in npj Parkinson’s Disease, researchers have unveiled compelling evidence that advances our understanding of Parkinson’s ...
In a groundbreaking new study published in npj Parkinson’s Disease, researchers are challenging existing paradigms about the genetic underpinnings of ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine